B. J. Stoll, N. Hansen, A. A. Fanaroff, L. L. Wright, W. A. Carlo et al., Late-onset sepsis in very low birth weight neonates: the experience of the NICHD Neonatal Research Network, Pediatrics, vol.110, issue.2, pp.285-91, 2002.

W. J. Steinbach, Pediatric Invasive Candidiasis: Epidemiology and Diagnosis in Children, Journal of fungi, vol.2, issue.1, 2016.

D. K. Benjamin and B. J. Stoll, Infection in late preterm infants, Clinics in perinatology, vol.33, issue.4, pp.871-82, 2006.

D. K. Benjamin, B. J. Stoll, M. G. Gantz, M. C. Walsh, P. J. Sanchez et al., Neonatal candidiasis: epidemiology, risk factors, and clinical judgment, Pediatrics, vol.126, issue.4, pp.865-73, 2010.

S. Aliaga, R. H. Clark, M. Laughon, T. J. Walsh, W. W. Hope et al., Changes in the incidence of candidiasis in neonatal intensive care units, Pediatrics, vol.133, issue.2, pp.236-278, 2014.

M. S. Kelly, D. K. Benjamin, J. Smith, and P. B. , The epidemiology and diagnosis of invasive candidiasis among premature infants, Clinics in perinatology, vol.42, issue.1, pp.105-122, 2015.

I. R. Makhoul, I. Kassis, T. Smolkin, A. Tamir, and P. Sujov, Review of 49 neonates with acquired fungal sepsis: further characterization, Pediatrics, vol.107, issue.1, pp.61-67, 2001.

P. Manzoni, M. Mostert, P. Galletto, L. Gastaldo, E. Gallo et al., Is thrombocytopenia suggestive of organism-specific response in neonatal sepsis? Pediatrics international : official journal of the, Japan Pediatric Society, vol.51, issue.2, pp.206-216, 2009.

G. Distefano, R. Curreri, P. Betta, M. G. Romeo, and M. Amato, Procalcitonin serum levels in perinatal bacterial and fungal infection of preterm infants, Acta Paediatr, vol.93, issue.2, pp.216-225, 2004.

B. De-pauw, T. J. Walsh, J. P. Donnelly, D. A. Stevens, J. E. Edwards et al., Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group, Clin Infect Dis, vol.46, issue.12, pp.1813-1834, 2008.

C. J. Clancy and M. H. Nguyen, Finding the "missing 50%" of invasive candidiasis: how nonculture diagnostics will improve understanding of disease spectrum and transform patient care, Clin Infect Dis, vol.56, issue.9, pp.1284-92, 2013.

T. G. Connell, M. Rele, D. Cowley, J. P. Buttery, and N. Curtis, How reliable is a negative blood culture result? Volume of blood submitted for culture in routine practice in a children's hospital, Pediatrics, vol.119, issue.5, pp.891-897, 2007.

A. N. Ellepola and C. J. Morrison, Laboratory diagnosis of invasive candidiasis, Journal of microbiology, vol.43, pp.65-84, 2005.

R. G. Greenberg, D. K. Benjamin, J. Gantz, M. G. Cotten, C. M. Stoll et al., Empiric antifungal therapy and outcomes in extremely low birth weight infants with invasive candidiasis, The Journal of pediatrics, vol.161, issue.2, pp.264-273, 2012.

L. Trovato, P. Betta, M. G. Romeo, and S. Oliveri, Detection of fungal DNA in lysis-centrifugation blood culture for the diagnosis of invasive candidiasis in neonatal patients. Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases, vol.18, pp.63-68, 2012.

J. T. Ramos, S. Villar, E. Bouza, E. Bergon-sendin, P. Rivilla et al., Performance of a Quantitative PCR-Based Assay and Beta-d-Glucan Detection for Diagnosis of Invasive Candidiasis in Very-Low-Birth-Weight Preterm Neonatal Patients (CANDINEO Study), Journal of clinical microbiology, vol.55, issue.9, pp.2752-64, 2017.

A. Onishi, D. Sugiyama, Y. Kogata, J. Saegusa, T. Sugimoto et al., Diagnostic accuracy of serum 1,3-beta-D-glucan for pneumocystis jiroveci pneumonia, invasive candidiasis, and invasive aspergillosis: systematic review and meta-analysis, Journal of clinical microbiology, vol.50, issue.1, pp.7-15, 2012.

J. Guitard, M. D. Tabone, Y. Senghor, C. Cros, D. Moissenet et al., Detection of beta-Dglucan for the diagnosis of invasive fungal infection in children with hematological malignancy, The Journal of infection, vol.73, issue.6, pp.607-622, 2016.

D. E. Karageorgopoulos, E. K. Vouloumanou, F. Ntziora, A. Michalopoulos, P. I. Rafailidis et al., beta-D-glucan assay for the diagnosis of invasive fungal infections: a meta-analysis, Clin Infect Dis, vol.52, issue.6, pp.750-70, 2011.

C. Angebault, F. Lanternier, F. Dalle, C. Schrimpf, A. L. Roupie et al., Prospective Evaluation of Serum beta-Glucan Testing in Patients With Probable or Proven Fungal Diseases. Open forum infectious diseases, vol.3, p.128, 2016.

D. K. Benjamin, C. Poole, W. J. Steinbach, J. L. Rowen, and T. J. Walsh, Neonatal candidemia and end-organ damage: a critical appraisal of the literature using meta-analytic techniques, Pediatrics, vol.112, issue.3, pp.634-674, 2003.

M. Mcinnes, D. Moher, B. D. Thombs, T. A. Mcgrath, P. M. Bossuyt et al., Preferred Reporting Items for a Systematic Review and Meta-analysis of Diagnostic Test Accuracy Studies: The PRISMA-DTA Statement, JAMA, vol.319, issue.4, pp.388-96, 2018.

M. M. Leeflang, R. J. Scholten, A. W. Rutjes, J. B. Reitsma, and P. M. Bossuyt, Use of methodological search filters to identify diagnostic accuracy studies can lead to the omission of relevant studies, Journal of clinical epidemiology, vol.59, issue.3, pp.234-274, 2006.

S. He, J. P. Hang, L. Zhang, F. Wang, D. C. Zhang et al., A systematic review and meta-analysis of diagnostic accuracy of serum 1,3-beta-D-glucan for invasive fungal infection: Focus on cutoff levels, vol.48, pp.351-61, 2015.

P. G. Pappas, C. A. Kauffman, D. R. Andes, C. J. Clancy, K. A. Marr et al., Clinical Practice Guideline for the Management of Candidiasis: 2016 Update by the Infectious Diseases Society of America, Clin Infect Dis, vol.62, issue.4, pp.1-50, 2016.

M. Cuenca-estrella, P. E. Verweij, M. C. Arendrup, S. Arikan-akdagli, J. Bille et al., ESCMID* guideline for the diagnosis and management of Candida diseases 2012: diagnostic procedures. Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases, vol.18, pp.9-18, 2012.

W. W. Hope, E. Castagnola, A. H. Groll, E. Roilides, M. Akova et al., ESCMID* guideline for the diagnosis and management of Candida diseases 2012: prevention and management of invasive infections in neonates and children caused by Candida spp. Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases, vol.18, pp.38-52, 2012.

P. F. Whiting, A. W. Rutjes, M. E. Westwood, S. Mallett, J. J. Deeks et al., QUADAS-2: a revised tool for the quality assessment of diagnostic accuracy studies, Annals of internal medicine, vol.155, issue.8, pp.529-565, 2011.

J. B. Reitsma, A. S. Glas, A. W. Rutjes, R. J. Scholten, P. M. Bossuyt et al., Bivariate analysis of sensitivity and specificity produces informative summary measures in diagnostic reviews, Journal of clinical epidemiology, vol.58, issue.10, pp.982-90, 2005.

H. Tabl, A. M. Saeed, and N. T. Abed, -3)-?-D-glucan in Neonatal Candidemia and its Reactivity with Bacterial Blood Stream Infection, Egyptian Journal of Medical Microbiology, vol.21, issue.1, pp.69-78, 2012.

P. Cliquennois, F. Morio, D. Navas, C. Flamant, E. Launay et al., Diagnostic accuracy of Beta-D-Glucan for detecting invasive candidiasis in neonates (unpublished), 2018.

J. Cohen, A. Ouziel, M. Chalumeau, C. Gras-leguen, E. Launay et al., Intérêt du (1,3)-béta-D-glucane pour le diagnostic de candidose invasive chez le nouveau-né, Médecine Mal Infect, vol.47, issue.4, p.120, 2017.

M. Cornu, S. Goudjil, G. Kongolo, A. Leke, D. Poulain et al., Evaluation of the (1,3)-beta-Dglucan assay for the diagnosis of neonatal invasive yeast infections, Medical mycology, vol.56, issue.1, pp.78-87, 2018.

S. Goudjil, G. Kongolo, L. Dusol, F. Imestouren, M. Cornu et al., -3)-beta-D-glucan levels in candidiasis infections in the critically ill neonate. The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstet, vol.26, pp.44-52, 2013.

C. A. Mackay, D. E. Ballot, and O. Perovic, Serum 1,3-betaD-Glucan assay in the diagnosis of invasive fungal disease in neonates, Pediatric reports, vol.3, issue.2, p.14, 2011.

M. T. Montagna, C. Coretti, G. Lovero, D. Giglio, O. Montagna et al., Diagnostic performance of 1-->3-beta-d-glucan in neonatal and pediatric patients with Candidemia. International journal of molecular sciences, vol.12, pp.5871-5878, 2011.

A. R. Huppler, B. T. Fisher, T. Lehrnbecher, T. J. Walsh, and W. J. Steinbach, Role of Molecular Biomarkers in the Diagnosis of Invasive Fungal Diseases in Children, J Pediatric Infect Dis Soc, vol.6, issue.suppl_1, pp.32-44, 2017.

Y. Liu, F. Chen, X. Zhu, L. Shen, and S. X. Zhang, Evaluation of a Novel Plasma (1,3)-beta-d-Glucan Detection Assay for Diagnosis of Candidemia in Pediatric Patients, Journal of clinical microbiology, vol.53, issue.9, pp.3017-3037, 2015.

D. Zhao, G. Qiu, Z. Luo, and Y. Zhang, Platelet parameters and (1, 3)-beta-D-glucan as a diagnostic and prognostic marker of invasive fungal disease in preterm infants, PLoS One, vol.10, issue.4, p.123907, 2015.

A. E. Shabaan, L. M. Elbaz, W. M. El-emshaty, and B. Shouman, Role of serum (1,3)-beta-d-glucan assay in early diagnosis of invasive fungal infections in a neonatal intensive care unit, Jornal de pediatria, vol.94, issue.5, pp.559-65, 2018.

C. Leon, S. Ruiz-santana, P. Saavedra, B. Almirante, J. Nolla-salas et al., Candida score") for early antifungal treatment in nonneutropenic critically ill patients with Candida colonization, Crit Care Med, vol.34, issue.3, pp.730-737, 2006.